Literature DB >> 9002674

Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells.

H Teng1, M Jorissen, H Van Poppel, E Legius, J J Cassiman, H Cuppens.   

Abstract

CFTR transcripts have been qualitatively and quantitatively analysed in nasal epithelial and vas deferens cells by means of reverse transcription PCR. Alternative splicing of exon 9, which is known to occur in nasal epithelial cells, also occurred in vas deferens cells. The extent of this alternative splicing was determined by the allele present at the Tn locus at the end of intron 8 of the CFTR gene. However, the proportion of transcripts lacking exon 9 sequences was increased in vas deferens cells compared with nasal epithelial cells, independent of the Tn genotype. We postulate that this tissue specific difference in the proportion of CFTR transcripts lacking exon 9 sequences could contribute to the tissue specific disease phenotype observed in individuals with congenital bilateral absence of the vas deferens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002674     DOI: 10.1093/hmg/6.1.85

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

1.  Long-range (17.7 kb) allele-specific polymerase chain reaction method for direct haplotyping of R117H and IVS-8 mutations of the cystic fibrosis transmembrane regulator gene.

Authors:  Genevieve Pont-Kingdon; Mohamed Jama; Christine Miller; Alison Millson; Elaine Lyon
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

2.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

3.  Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.

Authors:  H Cuppens; W Lin; M Jaspers; B Costes; H Teng; A Vankeerberghen; M Jorissen; G Droogmans; I Reynaert; M Goossens; B Nilius; J J Cassiman
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 4.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

5.  The CFTR polymorphisms poly-T, TG-repeats and M470V in Chinese males with congenital bilateral absence of the vas deferens.

Authors:  Wu-Hua Ni; Lei Jiang; Qian-Jin Fei; Jian-Yuan Jin; Xu Yang; Xue-Feng Huang
Journal:  Asian J Androl       Date:  2012-07-30       Impact factor: 3.285

6.  Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD.

Authors:  A de Meeus; C Guittard; M Desgeorges; S Carles; J Demaille; M Claustres
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

7.  Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping.

Authors:  Timothy W Hefferon; Fiona C Broackes-Carter; Ann Harris; Garry R Cutting
Journal:  Am J Hum Genet       Date:  2002-06-13       Impact factor: 11.025

8.  CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3.

Authors:  Gwendal Dujardin; Emanuele Buratti; Nicolas Charlet-Berguerand; Mafalda Martins de Araujo; Annick Mbopda; Catherine Le Jossic-Corcos; Franco Pagani; Claude Ferec; Laurent Corcos
Journal:  Nucleic Acids Res       Date:  2010-07-14       Impact factor: 16.971

9.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

10.  Elucidating clinical phenotypic variability associated with the polyT tract and TG repeats in CFTR.

Authors:  Keith Nykamp; Rebecca Truty; Darlene Riethmaier; Julia Wilkinson; Sara L Bristow; Sienna Aguilar; Dana Neitzel; Nicole Faulkner; Swaroop Aradhya
Journal:  Hum Mutat       Date:  2021-07-10       Impact factor: 4.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.